Searched for
SUMMIT THERAPEUTICS SHARE PRICE
Why is Summit Therapeutics share price up today by 22%?Summit Therapeutics share price is up today by 22% after biopharma firm announced AstraZeneca would invest $2 billion in it. British drugma...- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25% according to analystsThe coming earnings season will reflect the impact of the bad monsoon, higher oil prices, and, in pockets, higher inflation. Given that, in...
- India joins SCO meeting in Islamabad to prepare for 2027 leaders' summitIndia is participating in a three-day meeting of the Shanghai Cooperation Organisation in Islamabad, which began on Monday. This meeting ai...
- Why is Nvidia share price up today?Nvidia's share or stock (NVDA) price is rising by 2.9% today. The share price is $225.07 USD on the NASDAQ. The chip making company has rec...
- Sun Pharma signs major deal with LIB Therapeutics of US, gains access to $3.7-bn global market for bad cholesterol inhibitor PCSK9Sun Pharma has signed an exclusive agreement with LIB Therapeutics for Lerodalcibep, a cholesterol-lowering medication. This deal covers al...
- Top Nifty50 stocks analysts suggest buying in this volatile weekStock Reports Plus, powered by Refinitiv, is a comprehensive report that evaluates five key components of 4,000+ listed stocks – earnings, ...
- Two Trades for Today: An auto ancillary for a 7.05% gain, a large-cap electronics maker’s stock for an almost 8% riseOur technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Global Market: European shares rise as oil prices ease; Middle East tensions keep investors cautiousEuropean shares rose on Friday as easing oil prices supported risk appetite, while investors remained cautious over Middle East tensions. T...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- Global Market: Hong Kong stocks slide as investors await Trump-Xi summit detailsHong Kong stocks declined sharply on Friday, led by technology and AI shares, as investors awaited clarity from the Trump-Xi summit. The Ha...
- Vitruvias Therapeutics thyroid tablet recall gets FDA’s highest-risk rating - here’s what to check and what patients need to knowA thyroid medicine recall has received the FDA’s highest-risk classification after testing found one lot of Thyroid Tablets, USP 30 mg coul...
- Why US stocks are down: Dow, Nasdaq slide as Iran tensions push oil, yields higher amid Trump-Xi talksWall Street's main stock indexes fell as Middle East tensions weighed on financial markets. Oil prices have risen, which is causing a spike...
- Vitruvias Therapeutics thyroid tablet recall: FDA issues serious Class I warning over ‘superpotent’ medicine — check lot number, expiration date and what patients should knowVitruvias Therapeutics thyroid tablet recall: The FDA has issued a serious Class I recall for one lot of Vitruvias Therapeutics thyroid tab...
- Global Market: European shares edge lower as Middle East tensions, US-China talks in focusEuropean shares fell amid investor caution as tensions in the Middle East affecting energy markets persisted. Oil prices remained above $10...
- Didn’t get NSE IPO shares? Should you buy after listing, wait for a dip or bet on BSE?NSE Shares: As the National Stock Exchange (NSE) emerges on the market, investors are presented with various investment avenues. Options in...
- NSE shares jump 5% after muted debut, market value swells by Rs 19,290 crore. Why Macquarie, other brokerages are bullishNSE Share Price: National Stock Exchange shares made their market debut at Rs 1,800, which is slightly above the IPO price. The listing ref...
- Celldex shares slip 15% as safety concerns cloud skin drug trial win(Rewrites throughout to add company comments, adds shares in paragraph 2, analyst comment in paragraph 5)- Celldex Therapeutics said on Tue...
- Ichor Biologics seeks $80-100 million PE funding for minority stake saleIchor Biologics is seeking eighty to one hundred million dollars from private equity investors. The Hyderabad-based company operates in the...
- Top Nifty50 stocks analysts suggest buying in this volatile weekStock Reports Plus, powered by Refinitiv, is a comprehensive report that evaluates five key components of 4,000+ listed stocks – earnings, ...
Load More
